Cas:1052714-46-1 6-Bromo-5-fluoro-2-pyridinecarboxylic acid manufacturer & supplier

Chemical Name:6-Bromo-5-fluoro-2-pyridinecarboxylic acid

CAS.NO:1052714-46-1

Synonyms:6-Bromo-5-fluoropyridine-2-carboxylic acid;6-Bromo-5-fluoro-2-pyridinecarboxylic acid;2-Pyridinecarboxylic acid, 6-bromo-5-fluoro-

Molecular Formula:C₆H₃BrFNO₂

Molecular Weight:219.996

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:331.3±42.0 °C at 760 mmHg

Density:1.9±0.1 g/cm3

Index of Refraction:1.589

PSA:50.19000

Exact Mass:218.933105

LogP:0.83

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 6-Bromo-5-fluoropyridine-2-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Pyridinecarboxylic acid, 6-bromo-5-fluoro- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Pyridinecarboxylic acid, 6-bromo-5-fluoro- Use and application,6-Bromo-5-fluoro-2-pyridinecarboxylic acid technical grade,usp/ep/jp grade.

Related News: Looking after their staff: Airlines are under pressure from their staff, who obviously want to protect themselves. 6-Bromo-5-fluoro-2-pyridinecarboxylic acid manufacturer Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML). 6-Bromo-5-fluoro-2-pyridinecarboxylic acid supplier Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML). 6-Bromo-5-fluoro-2-pyridinecarboxylic acid vendor Any US citizen who has been in China’s Hubei province — epicenter of the outbreak — in the last 14 days will be allowed back into the country. 6-Bromo-5-fluoro-2-pyridinecarboxylic acid factory In August, the Company announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,370,452 covering compositions and uses of effector T cells expressing a CAR, where such T cells are derived from a pluripotent stem cell, including an iPSC.